Citadel Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-20,463
| Closed | -$82K | – | 5601 |
|
|
2019
Q4 | $82K | Sell |
20,463
-76,293
| -79% | -$306K | ﹤0.01% | 4325 |
|
|
2019
Q3 | $474K | Buy |
+96,756
| New | +$474K | ﹤0.01% | 3511 |
|
|
2019
Q2 | – | Sell |
-709,790
| Closed | -$4.12M | – | 5350 |
|
|
2019
Q1 | $4.12M | Buy |
709,790
+559,866
| +373% | +$3.25M | ﹤0.01% | 1712 |
|
|
2018
Q4 | $2.02M | Buy |
149,924
+126,228
| +533% | +$1.7M | ﹤0.01% | 2206 |
|
|
2018
Q3 | $459K | Sell |
23,696
-104,944
| -82% | -$2.03M | ﹤0.01% | 3212 |
|
|
2018
Q2 | $3.29M | Buy |
128,640
+55,253
| +75% | +$1.41M | ﹤0.01% | 1746 |
|
|
2018
Q1 | $1.48M | Buy |
73,387
+62,854
| +597% | +$1.27M | ﹤0.01% | 2153 |
|
|
2017
Q4 | $211K | Sell |
10,533
-7,880
| -43% | -$158K | ﹤0.01% | 3365 |
|
|
2017
Q3 | $381K | Sell |
18,413
-998,387
| -98% | -$20.7M | ﹤0.01% | 2839 |
|
|
2017
Q2 | $15M | Sell |
1,016,800
-708,529
| -41% | -$10.5M | 0.01% | 691 |
|
|
2017
Q1 | $27.5M | Buy |
1,725,329
+1,179,253
| +216% | +$18.8M | 0.03% | 476 |
|
|
2016
Q4 | $6.88M | Buy |
546,076
+437,471
| +403% | +$5.51M | 0.01% | 900 |
|
|
2016
Q3 | $3.04M | Buy |
+108,605
| New | +$3.04M | ﹤0.01% | 1317 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4142 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4225 |
|
|
2015
Q4 | – | Sell |
-5,417
| Closed | -$156K | – | 4456 |
|
|
2015
Q3 | $156K | Sell |
5,417
-8,316
| -61% | -$239K | ﹤0.01% | 3264 |
|
|
2015
Q2 | $615K | Buy |
13,733
+12,698
| +1,227% | +$569K | ﹤0.01% | 2428 |
|
|
2015
Q1 | $36K | Buy |
+1,035
| New | +$36K | ﹤0.01% | 3446 |
|